Paper23922111
MicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial.
Hansen TF and 5 others. Br J Cancer, 2013. Cited by 60 papers, by iCite.
Cite this record
ConductScience Library. MicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial. Papers, record 23922111. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23922111
- Disease
- colorectal cancer741 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics35
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colorectal Neoplasms | Major topic |
| Endothelial Growth Factors | Major topic |
| MicroRNAs | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Angiogenesis Inhibitors | |
| Antibodies, Monoclonal, Humanized | |
| Antineoplastic Combined Chemotherapy Protocols | |
| Bevacizumab | |
| Biomarkers, Tumor | |
| Calcium-Binding Proteins | |
| Camptothecin | |
| Capecitabine | |
| Denmark | |
| Deoxycytidine | |
| Disease-Free Survival | |
| EGF Family of Proteins | |
| ErbB Receptors | |
| Erlotinib Hydrochloride | |
| Female | |
| Fluorouracil | |
| Humans | |
| Leucovorin | |
| Male | |
| Middle Aged | |
| Neovascularization, Pathologic | |
| Organoplatinum Compounds | |
| Oxaloacetates | |
| Polymorphism, Single Nucleotide | |
| Protein Kinase Inhibitors | |
| Quinazolines | |
| Sweden | |
| Treatment Outcome | |
| Vascular Endothelial Growth Factor A |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00598156 | Chemotherapy and Avastin Followed by Maintenance Treatment With Avastin +/- Tarceva | Derived from the trial | Yes |
Source ClinicalTrials.gov
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17626061 | EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution. | Development | 2007 | https://conductscience.org/library/papers/17626061 | PubMed |
| 2 | 21046227 | Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk. | Breast Cancer Res Treat | 2011 | https://conductscience.org/library/papers/21046227 | PubMed |
| 3 | 19184059 | A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer. | Int J Colorectal Dis | 2009 | https://conductscience.org/library/papers/19184059 | PubMed |
| 4 | 22037871 | Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation. | Cancer Res | 2011 | https://conductscience.org/library/papers/22037871 | PubMed |
| 5 | 22170610 | A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. | Nature | 2011 | https://conductscience.org/library/papers/22170610 | PubMed |
| 6 | 18197166 | Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? | Nat Rev Genet | 2008 | https://conductscience.org/library/papers/18197166 | PubMed |
| 7 | 18694566 | miR-126 regulates angiogenic signaling and vascular integrity. | Dev Cell | 2008 | https://conductscience.org/library/papers/18694566 | PubMed |
| 8 | 10655437 | New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. | J Natl Cancer Inst | 2000 | https://conductscience.org/library/papers/10655437 | PubMed |
| 9 | 18185580 | Endogenous human microRNAs that suppress breast cancer metastasis. | Nature | 2008 | https://conductscience.org/library/papers/18185580 | PubMed |
| 10 | 15085134 | The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation. | Nature | 2004 | https://conductscience.org/library/papers/15085134 | PubMed |
| 11 | 18521848 | Deregulated expression of miR-106a predicts survival in human colon cancer patients. | Genes Chromosomes Cancer | 2008 | https://conductscience.org/library/papers/18521848 | PubMed |
| 12 | 20034472 | miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7. | Biochem Biophys Res Commun | 2010 | https://conductscience.org/library/papers/20034472 | PubMed |
| 13 | 18663744 | The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. | Genes Chromosomes Cancer | 2008 | https://conductscience.org/library/papers/18663744 | PubMed |
| 14 | 19824075 | Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma. | Hepatology | 2009 | https://conductscience.org/library/papers/19824075 | PubMed |
| 15 | 20585341 | Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan. | Pharmacogenomics J | 2011 | https://conductscience.org/library/papers/20585341 | PubMed |
| 16 | 20680522 | Down-regulation of miR-126 expression in colorectal cancer and its clinical significance. | Med Oncol | 2011 | https://conductscience.org/library/papers/20680522 | PubMed |
| 17 | 16557279 | Oncomirs - microRNAs with a role in cancer. | Nat Rev Cancer | 2006 | https://conductscience.org/library/papers/16557279 | PubMed |
| 18 | 22139032 | The predictive value of single nucleotide polymorphisms in the VEGF system to the efficacy of first-line treatment with bevacizumab plus chemotherapy in patients with metastatic colorectal cancer: results from the Nordic ACT trial. | Int J Colorectal Dis | 2012 | https://conductscience.org/library/papers/22139032 | PubMed |
| 19 | 22160377 | EGFL7: a unique angiogenic signaling factor in vascular development and disease. | Blood | 2012 | https://conductscience.org/library/papers/22160377 | PubMed |
| 20 | 20953557 | miR-126 and miR-126*: new players in cancer. | ScientificWorldJournal | 2010 | https://conductscience.org/library/papers/20953557 | PubMed |
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42564030 | Tumor-derived miR-126 promotes tumor progression through immune modulation beyond the local tumor environment. | Front Oncol | 2026 | https://conductscience.org/library/papers/42564030 | PubMed |
| 41331186 | Regulatory roles of non-coding and exosomal RNAs in colorectal cancer: spotlight on angiogenesis. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/41331186 | PubMed |
| 38213742 | Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies. | Stem Cells Int | 2024 | https://conductscience.org/library/papers/38213742 | PubMed |
| 36051356 | A Systematic Review of Clinical Validated and Potential miRNA Markers Related to the Efficacy of Fluoropyrimidine Drugs. | Dis Markers | 2022 | https://conductscience.org/library/papers/36051356 | PubMed |
| 35399721 | MiR-211-5p Inhibits the Biological Behaviors of Colorectal Cancer via SPARC-Related Growth Factor Pathways. | J Cancer | 2022 | https://conductscience.org/library/papers/35399721 | PubMed |
| 34443215 | miRNA-146a and miRNA-126 as Potential Biomarkers in Patients with Coronary Artery Disease and Generalized Periodontitis. | Materials (Basel) | 2021 | https://conductscience.org/library/papers/34443215 | PubMed |
| 34208056 | The Clinical Assessment of MicroRNA Diagnostic, Prognostic, and Theranostic Value in Colorectal Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34208056 | PubMed |
| 33953222 | High expression of microRNA-126 relates to favorable prognosis for colon cancer patients. | Sci Rep | 2021 | https://conductscience.org/library/papers/33953222 | PubMed |
| 33865381 | MicroRNAs and angiogenesis: a new era for the management of colorectal cancer. | Cancer Cell Int | 2021 | https://conductscience.org/library/papers/33865381 | PubMed |
| 33598796 | Tissue micro-RNAs associated with colorectal cancer prognosis: a systematic review. | Mol Biol Rep | 2021 | https://conductscience.org/library/papers/33598796 | PubMed |
| 33363035 | Molecular Alterations in Metastatic Ovarian Cancer From Gastrointestinal Cancer. | Front Oncol | 2020 | https://conductscience.org/library/papers/33363035 | PubMed |
| 33165429 | Downregulation of miR-10a inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion by targeting Syndecan-1. | Int J Clin Exp Pathol | 2020 | https://conductscience.org/library/papers/33165429 | PubMed |
| 32197436 | Current and New Predictors for Treatment Response in Metastatic Colorectal Cancer. The Role of Circulating miRNAs as Biomarkers. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32197436 | PubMed |
| 31281458 | High expression of CDH3 predicts a good prognosis for colon adenocarcinoma patients. | Exp Ther Med | 2019 | https://conductscience.org/library/papers/31281458 | PubMed |
| 30197478 | Long non-coding RNAs involved in metastasis of gastric cancer. | World J Gastroenterol | 2018 | https://conductscience.org/library/papers/30197478 | PubMed |
| 30104884 | LINC00888 promoted tumorigenicity of melanoma via miR-126/CRK signaling axis. | Onco Targets Ther | 2018 | https://conductscience.org/library/papers/30104884 | PubMed |
| 29750053 | Prognostic value of microRNAs in colorectal cancer: a meta-analysis. | Cancer Manag Res | 2018 | https://conductscience.org/library/papers/29750053 | PubMed |
| 29416688 | KSHV LANA upregulates the expression of epidermal growth factor like domain 7 to promote angiogenesis. | Oncotarget | 2018 | https://conductscience.org/library/papers/29416688 | PubMed |
| 28980146 | Egfl7 Represses the Vasculogenic Potential of Human Endothelial Progenitor Cells. | Stem Cell Rev Rep | 2018 | https://conductscience.org/library/papers/28980146 | PubMed |
| 28573140 | Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs. | Biomed Res Int | 2017 | https://conductscience.org/library/papers/28573140 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CALD1 | 800 | PubTator's text mining | https://conductscience.org/library/genes/800 | NCBI Gene |
| CD34 | 947 | PubTator's text mining | https://conductscience.org/library/genes/947 | NCBI Gene |
| DICER1 | 23405 | PubTator's text mining | https://conductscience.org/library/genes/23405 | NCBI Gene |
| DROSHA | 29102 | PubTator's text mining | https://conductscience.org/library/genes/29102 | NCBI Gene |
| EGFL7 | 51162 | PubTator's text mining | https://conductscience.org/library/genes/51162 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| MIR126 | 406913 | PubTator's text mining | https://conductscience.org/library/genes/406913 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Drugs2
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| BEVACIZUMAB | CHEMBL1201583 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1201583 | ChEMBL |
| ERLOTINIB | CHEMBL553 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL553 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23922111
GET https://conductscience.org/api/papers/v1/23922111/references?page=2